Medical Doctor Program year 2024 Reported 2020–2024 Source: CMS Open Payments, 2026 publication

Nicholas Namias

Surgical Critical Care Miami, FL Medical Doctor

NPI 1326004227 CMS profile 685862

1611 Nw 12Th Ave, Box 016960 M851, Miami, FL 33136

Open in the dashboard

General payments

$12,849

18 records reported · program years 2020–2024

Research payments

$0

Paid to them · None reported · program years 2020–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Nicholas Namias of Miami, FL is reported in the CMS Open Payments database as having received $12,849 across 18 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Surgical Critical Care profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $6,776 10
2022 General $1,073 6
2021 General $2,500 1
2020 General $2,500 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nicholas Namias
  • Surgical Critical Care median
  • Middle half of Surgical Critical Care
  • National median

In program year 2025, general payments to Nicholas Namias were reported at $0. Among 1,068 Surgical Critical Care profiles paid that year, the median was $231 and the middle half received between $82 and $1,489.

Show as a table
Year Nicholas Namias Surgical Critical Care median Middle half National median
2019 $0 $161 $57–$631 $163
2020 $2,500 $116 $33–$383 $114
2021 $2,500 $121 $37–$475 $132
2022 $1,073 $163 $53–$789 $149
2023 $0 $188 $67–$1,031 $160
2024 $6,776 $216 $80–$1,133 $164
2025 $0 $231 $82–$1,489 $169

Breakdown

Who paid General payments · program years 2020–2024
  1. Molnlycke Health Care US, LLC $6,617 7 payments
  2. Merck Sharp & Dohme Corporation $5,000 2 payments
  3. CSL Behring $1,073 6 payments
  4. Baxter Healthcare $144 2 payments
  5. Urgo Medical North America, LLC $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2020–2024
  1. Consulting Fee $10,000 3 payments
  2. Travel and Lodging $2,082 6 payments
  3. Food and Beverage $767 9 payments
Products named General payments · program years 2020–2024
  1. Biogel PI Micro Indicator Underglove $5,155 3 payments
  2. Biogel PI Indicator Underglove $484 4 payments
  3. Biogel PI Micro $155 2 payments
  4. BIOGEL INDICATOR SYSTEM Gloves $155 2 payments
  5. FLOSEAL $144 2 payments
  6. Biogel PI $122 1 payment
  7. Biogel Indicator System Gloves $33 1 payment
  8. VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP $15 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 14 billing codes

Paid by Medicare

$31,100

Medicare's payments for the services billed

Medicare patients

81

Average age 70

Services billed

210

41 women, 40 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 57%
Chronic kidney disease 56%
Diabetes 54%
Arthritis 47%
Heart failure 46%
Depression 41%
Atrial fibrillation 36%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

18 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record